| Summary: | 碩士 === 嘉南藥理大學 === 藥學系 === 102 === For diabetes prevention, the government on public health policy is actively promoting the "diabetes share care" Among many of the current health care system, diabetes share care is considered the most achievement system, signifying its importance. This study aimed to understand the two primary health care units in whether to participate in "diabetes share care" controlled observation studies on their medication patterns do. In this study, a retrospective chart control observation, coupled with a questionnaire to make supplementary information. In this study, Tainan two primary health care units, a participation in "diabetes share care" and the other one is not joined to each of 80 (total 160). In interviews and medical record review of data collected in these cases, re-use Excel and SPSS 12.0 software package for statistical analysis.
The results showed that the average age of each of the two groups shared care group (67.1 ± 9.7), the traditional group (68.7 ± 10.4), no sex and age differences, mostly in the lower socio-economic status, only two oral medication model is almost the way (shared care group 98.8% vs traditional care group 97.5%). Traditional group often Sulfonylurea drugs as a first choice, shared care group often Biguanide. The amount of the second drug in the traditional group is Biguanide, shared care group is Sulfonylurea. Two groups most Merger with two kinds of oral medication, as expected Biguanide + Sulfonylurea is a major partner. As for the use of more advanced pen needle insulin has scattered two groups ( in the traditional group: 2; shared care groups: 1),Mobidity Index 2 groups ofshared care were 3.8±1.7 vs traditional group 2.9 ±1.4,and no difference in Co- morbidity index(CCI-Q) (1.5±0.7). Other types of medication according to ATC code, used in the case of two groups in order, are the largest class in the digestive tract and metabolism, followed by cardiovascular, skeletal muscle and joint medication; their drug items (shared care group 3.2 ± 1.3 vs tradition group, 2.8 ± 1.2). In the important indicators of diabetes monitoring of HbA1c differences (shared care group8.9 ± 2.2 vs traditional group 7.7 ± 1.6), although there are significance (p <0.05) on the statistics, but it is not easy to comment righteousness culvert.
One of the bottlenecks for diabetes prevention and treatment is medication knowledge of patients: two groups are still only a small part of the understanding, and most do not know, but there are particular differences not due to shared care or traditional methods. Apparently "common diabetes care network" necessity to intervene to assist pharmacists in primary care system.Pharmacists can integrate and monitor pharmaceutical care to implement holistic nature of diabetes care. On patient care will be better improved.
|
|---|
